Condition
Silent Atherosclerosis
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
4 treatments under study, led by Aspirin 75 Mg Daily Clopidgrel 75 Mg Daily
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Not Yet Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Aspirin 75 Mg Daily Clopidgrel 75 Mg Daily1
- Clopidgrel 75 Mg Daily1
- Clopidogrel 75 Mg Daily1
- Aspirin 75 Mg Daily1
Active Sponsors
- Guys And St Thomas Nhs Foundation Trust1
- Kings College London1
Related Conditions
- Peripheral Arterial Disease1